The HPV Vaccination Policy and Advocacy Research Project is on a mission to ensure equitable access to the HPV vaccine in Nigeria and other low- and middle-income countries (LMICs) as part of a suite of interventions to curb cervical cancer. This research is critical to ensuring the effective and evidence-based rollout of Nigeria’s HPV Vaccination program.
The team is currently conducting focus group discussions and in-depth interviews to build on initial desk review findings. These qualitative interviews go beyond the surface, gathering nuanced perspectives to design more effective, tailored and sustainable service delivery and demand-generation strategies for eligible adolescent girls.
Early findings show promise. Researchers have identified delivery strategies that could work best based on existing vaccination coverage in different regions. The team also assessed potential outcomes across the country. These insights will be invaluable as they collaborate with Nigeria’s National Primary Health Care Development Agency (NPHCDA) to craft the most effective strategies to inform phase 2 of the HPV vaccine rollout, and also its routinization into the country’s routine immunisation and adolescent health programs.
